David Hung - 16 Jun 2025 Form 4 Insider Report for Nuvation Bio Inc. (NUVB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Jun 2025, 16:05:05 UTC
Prior SEC filing
06 Jun 2025
Next SEC filing
03 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Stephen Dang, Attorney-in-Fact

Key filing fact

David Hung filed Form 4 for Nuvation Bio Inc. (NUVB) on 18 Jun 2025.

Key facts

  • This page summarizes David Hung's Form 4 filing for Nuvation Bio Inc. (NUVB).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Jun 2025, 16:05.

Change

  • Previous filing in this sequence was filed on 06 Jun 2025.
  • Current net transaction value: +$893,500.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001310880 Primary reporting owner

Hung David

Relationship
PRESIDENT AND CEO, Director, 10%+ Owner
Address
C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK
Signature
/s/ Stephen Dang, Attorney-in-Fact
Signature date
18 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUVB transaction

Class A Common Stock

Purchase

Transaction value
$893,500
Shares
+500,000
Change %
+0.85%
Price
$1.79
Shares after
59,281,054
Date
16 Jun 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

) The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.64 to $1.88, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .